Belsomra (Suvorexant) Adolescent Dosing: What Clinicians and Parents Need to Know
Evidence-based guide to suvorexant (Belsomra) dosing in adolescents aged 12-17, including FDA labeling gaps, off-label considerations, safety data, and mental-health monitoring.
Read clinical review